Navigation Links
EasySep PE Selection Kit, Other from StemCell Technologies, Inc.

ProductsEasySep PE Selection Kit, Other from StemCell Technologies, Inc.
Company StemCell Technologies, Inc.
Item EasySep PE Selection Kit, Other
Price 
Description This kit is designed to select cells labeled with phycoerythrin- (PE-) conjugated antibodies. Kit includes reagents for labeling 3 x 109 cells and EasySep magnet.
Info StemCell Technologies, Inc.StemCell Technologies, Inc.
570 West Seventh Avenue, Suite 400
Vancouver, BC, V5Z 1B3
Canada
Customer Service:
(604) 877-0713
(800) 667-0322

Fax Number:
(604) 877-0704
(800) 567-2899

Web Site: http://www.stemcell.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. EasySep Biotin Selection Kit, Other from StemCell Technologies, Inc.
2. EasySep PE Selection Kit, Other, Starter Kit from StemCell Technologies, Inc.
3. EasySep FITC Selection Kit, Other from StemCell Technologies, Inc.
4. EasySep Neg Mouse Combo Starter Kit from StemCell Technologies, Inc.
5. EasySep Mouse Combo Starter, Kit from StemCell Technologies, Inc.
6. FRT flanked, Pro and Euk. Neomycin Selection Cassette (FRT-PGK-gb2-neo-FRT) from Gene Bridges GmbH
7. loxP flanked, Pro and Euk. Neomycin Selection Cassette (loxP-PGK-gb2-neo-loxP) from Gene Bridges GmbH
8. FRT flanked, Pro and Euk. Neomycin Selection Cassette plus loxP site(FRT-PGK-gb2-neo-FRT-loxP) from Gene Bridges GmbH
9. loxP flanked Chloramphenicol Selection Cassette (loxP-cm-loxP) from Gene Bridges GmbH
10. FRT flanked Ampicillin Selection Cassette (FRT-amp-FRT) from Gene Bridges GmbH
11. loxP flanked Ampicillin Selection Cassette (loxP-amp-loxP) from Gene Bridges GmbH
Anti-FLIPgamma / delta (CT) Antibody, Unconjugated from QED Bioscience Inc.
Mouse Anti-Vancomycin Monoclonal Antibody, Unconjugated, Clone 2G1 from Abcam
Rabbit Anti-Human Rab1A Antibody, Unconjugated from Spring Bioscience
Chicken Anti-Human LYZL6 Polyclonal Antibody, Unconjugated from Abcam
Biology Products:
(Date:12/3/2009)...ear record low in Antarctic snowmelt that occurred...to concurrent strong positive phases for two main ...on) and SAM (Southern Hemisphere Annular Mode), ac...of Earth & Atmospheric Sciences at The City Colleg...o on the doctoral faculty at the CUNY Graduate Cen...
(Date:12/2/2009)...ELPHIA Cigarette smoking and alcohol consumption ...dicts the patient,s future risk of death, accordin...y show a similar effect among those who continued ...cer survivors are counseled to quit smoking; despi...t continued to smoke even after their cancer diagn...
(Date:12/2/2009)...PHIA Assurance of a cancer-free status did not pr...zed tomography (CT) lung-cancer screening program ...te in a study published in Cancer Epidemiology, B... Association for Cancer Research. The December iss...findings should negate widespread concern in the l...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Eastern Insurance Holdings Inc to Release 2nd Quarter 2009 Financial Results 52603 1Eastern Insurance Holdings Inc to Release 2nd Quarter 2009 Financial Results 52603 2Eastern Insurance Holdings Inc to Release 2nd Quarter 2009 Financial Results 52603 3U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 1U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 2U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 3U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 4U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 5U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 6U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 7U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 8U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 9U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 10U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 11U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 12U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 13U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 14Registered Dietitian Reveals Chronic Back Pain Relief through Diet in New Book Cookbook and Diet Program 52595 1Registered Dietitian Reveals Chronic Back Pain Relief through Diet in New Book Cookbook and Diet Program 52595 2
...vere United States wildfires can contribute as muc...s, although the amount is highly variable. New res...Carbon Balance and Management quantifies these emi...s monitoring and modelling efforts. , Christine W...esearch and Jason Neff of the University of Colora...
...ADISON - Far removed from streams of gas-thirsty c...key player in global climate change. Circling the... forests - one of the largest ecosystems on earth ...arbon levels. , Forest ecologists at the Universi...ntal factors such as forest fires and climate infl...
...ethesda, MD - The November 1st and November 15th i...physical Society, are now available online. Topic...nels that could payoff in synthetic drug design, t...structure of a Na+/H+ antiporter dimmer. , Volu...the Kv1.2 voltage-gated K+ channel in a Membrane E...
Other Biology News:US faces burning emissions issue 2Wildfire drives carbon levels in northern forests 2Media highlights in the November issues of Biophysical Journal 2Media highlights in the November issues of Biophysical Journal 3
(Date:12/2/2009)...r 2 , - "Bolstering Biodi..." , Coinciding with the International Yea...blic is hosting an international conference in Lib...gical resources in Africa. The,conference will be ...s,scientific experts, private companies, represen...
(Date:12/2/2009)...wire/ -- S*BIO Pte Ltd today announced data presen...at The American Society of Hematology 51st Annual ...will be presented on the clinical results from the... its safety, tolerability and pharmacokinetic/phar... from 100 to 600 mg. These doses were administered...
(Date:12/2/2009)...wire-Asia/ -- The world is going through,extraordi... is part of many,businesses and industries. It tur...y immune to the economic downturn, because illness...dst of the difficult times this year, the pharmace...R&D center in Shanghai, the largest of,its kin...
(Date:12/1/2009)...RNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) ...for the fourth quarter ended December 31, 2009 of ...llion for the fourth quarter of 2008. Included in ...nstallment payments of $12.5 million from Alexion.... a one-time $1.8 million payment from Genentech fo...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3